Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cyberonics Inc announces CE Mark approval of AspireSR generator for VNS therapy


Thursday, 20 Feb 2014 07:15am EST 

Cyberonics Inc:Says the CE Mark (ConformitĂ© EuropĂ©enne) approval in Europe for the AspireSR generator, the sixth-generation VNS Therapy generator.Says AspireSR generator provides the well-established benefits of VNS Therapy, coupled with a new feature - Automatic Stimulation in response to detection of a seizure.Says proprietary technology enables the AspireSR generator to analyze relative heart rate changes to detect and respond to seizures.Says this technology is based on a growing body of evidence that seizures are often accompanied by an increase in heart rate (ictal tachycardia).Says with the Automatic Stimulation feature, the AspireSR generator better aligns stimulation with the clinical onset of a seizure.